Trial Profile
A prospective observational 8-week follow-up study in a real setting assessing Efficacy and tolerability of Vortioxetine in the treatment of major depressive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2019
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 09 May 2018 Results (n=66) presented at the 171st Annual Meeting of the American Psychiatric Association
- 27 Nov 2017 New trial record